JP6509238B2 - 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 - Google Patents
治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 Download PDFInfo
- Publication number
- JP6509238B2 JP6509238B2 JP2016548033A JP2016548033A JP6509238B2 JP 6509238 B2 JP6509238 B2 JP 6509238B2 JP 2016548033 A JP2016548033 A JP 2016548033A JP 2016548033 A JP2016548033 A JP 2016548033A JP 6509238 B2 JP6509238 B2 JP 6509238B2
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidin
- pyrazolo
- dimethyl
- amine
- dimethoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14152202 | 2014-01-22 | ||
EP14152202.9 | 2014-01-22 | ||
PCT/EP2015/051177 WO2015110491A2 (en) | 2014-01-22 | 2015-01-21 | Pyrazolo[1,5-a]pyrimidin-7-amine derivatives useful in therapy |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017503830A JP2017503830A (ja) | 2017-02-02 |
JP2017503830A5 JP2017503830A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2018-02-22 |
JP6509238B2 true JP6509238B2 (ja) | 2019-05-08 |
Family
ID=49989585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016548033A Active JP6509238B2 (ja) | 2014-01-22 | 2015-01-21 | 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 |
Country Status (11)
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018248581B2 (en) * | 2017-04-05 | 2022-05-26 | Curovir Ab | Heteroaromatic compounds useful in therapy |
US11649238B2 (en) | 2018-01-17 | 2023-05-16 | Glaxosmithkline Intellectual Property Development Limited | Substituted pyrazolo[1,5-a]pyrimidines as PI4K inhibitors |
CN108727386A (zh) * | 2018-07-16 | 2018-11-02 | 广州医科大学 | 一种吡唑并嘧啶类化合物及其制备方法和用途 |
MX2020013039A (es) | 2018-08-21 | 2021-02-26 | Kyorin Seiyaku Kk | Derivado de anillo heteroaromatico biciclico. |
IL281956B2 (en) * | 2018-10-10 | 2024-07-01 | Curovir Ab | 2,6-DIMETHYL-N-((PYRIDlN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N- [(PYRIDlN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDlN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS |
WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
CN109988172B (zh) * | 2019-01-10 | 2020-09-29 | 石家庄学院 | 一种吡唑并[1,5-a]嘧啶类杂环化合物及衍生物的合成方法 |
EP4028131B1 (en) | 2019-08-20 | 2023-11-22 | Curovir Ab | Heteroaromatic compounds useful in therapy |
WO2024184442A1 (en) | 2023-03-09 | 2024-09-12 | Curovir Ab | Compound and formulation for systemic therapy by oral transmucosal administration |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2585462B2 (ja) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | ピラゾロ[1,5―a]ピリミジン誘導体 |
DE69130683T2 (de) * | 1991-04-22 | 1999-05-06 | Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima | PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
CA2379585C (en) * | 1999-09-30 | 2006-06-20 | James W. Darrow | Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
JP2005529919A (ja) * | 2002-05-10 | 2005-10-06 | スミスクライン ビーチャム コーポレーション | 治療用化合物 |
US7601724B2 (en) * | 2002-09-04 | 2009-10-13 | Schering Corporation | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
JP4790265B2 (ja) * | 2002-09-04 | 2011-10-12 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしての新規ピラゾロピリミジン |
GB0519957D0 (en) * | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
WO2010086040A1 (en) * | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
EP2539342B1 (en) * | 2010-02-26 | 2015-04-15 | Mitsubishi Tanabe Pharma Corporation | Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
US8633198B1 (en) * | 2011-09-20 | 2014-01-21 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
-
2015
- 2015-01-21 CA CA2935658A patent/CA2935658C/en active Active
- 2015-01-21 AU AU2015208205A patent/AU2015208205B2/en active Active
- 2015-01-21 JP JP2016548033A patent/JP6509238B2/ja active Active
- 2015-01-21 RU RU2016134130A patent/RU2689788C2/ru active
- 2015-01-21 US US15/107,930 patent/US9963455B2/en active Active
- 2015-01-21 WO PCT/EP2015/051177 patent/WO2015110491A2/en active Application Filing
- 2015-01-21 BR BR112016016798-8A patent/BR112016016798B1/pt active IP Right Grant
- 2015-01-21 ES ES15702990T patent/ES2954126T3/es active Active
- 2015-01-21 CN CN201580005612.2A patent/CN106061975B/zh active Active
- 2015-01-21 EP EP15702990.1A patent/EP3096762B1/en active Active
-
2016
- 2016-08-16 ZA ZA2016/05666A patent/ZA201605666B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015110491A2 (en) | 2015-07-30 |
US9963455B2 (en) | 2018-05-08 |
JP2017503830A (ja) | 2017-02-02 |
EP3096762A2 (en) | 2016-11-30 |
WO2015110491A3 (en) | 2015-09-17 |
RU2016134130A (ru) | 2018-02-26 |
CA2935658A1 (en) | 2015-07-30 |
CN106061975B (zh) | 2019-09-24 |
RU2689788C2 (ru) | 2019-05-29 |
RU2016134130A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2018-08-30 |
BR112016016798B1 (pt) | 2022-06-28 |
BR112016016798A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2017-08-08 |
AU2015208205B2 (en) | 2019-12-05 |
CN106061975A (zh) | 2016-10-26 |
EP3096762B1 (en) | 2023-06-28 |
NZ722290A (en) | 2021-08-27 |
ES2954126T3 (es) | 2023-11-20 |
ZA201605666B (en) | 2021-01-27 |
US20160318937A1 (en) | 2016-11-03 |
AU2015208205A1 (en) | 2016-08-18 |
EP3096762C0 (en) | 2023-06-28 |
CA2935658C (en) | 2023-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6509238B2 (ja) | 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 | |
RU2712196C2 (ru) | Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии | |
KR101846136B1 (ko) | Pde10 억제제 및 관련 조성물 및 방법 | |
JP7200126B2 (ja) | 療法において有用なヘテロ芳香族化合物 | |
JP6401249B2 (ja) | 2,3−ブタンジアミドエポキシド化合物ならびにその調製方法及び使用 | |
JP2022504082A (ja) | ウイルス感染を処置するための2,6-ジメチル-N-((ピリジン-4-イル)メチル)イミダゾ[1,2-b]ピリダジン-8-アミンおよび2,5-ジメチル-N-[(ピリジン-4-イル)メチル]ピラゾロ[1,5-a]ピリミジン-7-アミン誘導体 | |
CN107141287B (zh) | 2-亚胺-5-酮基-2,5-二氢-1-h-二吡啶并嘧啶类化合物 | |
JP6071012B2 (ja) | 4−アミノ−3−フェニルアミノ−6−フェニルピラゾロ[3,4−d]ピリミジン誘導体、その製造および抗ウイルス剤としての使用 | |
NZ722290B2 (en) | Pyrazolo[1,5-a]pyrimidin-7-amine derivatives useful in therapy | |
HK1254809B (en) | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy | |
HK1241362B (en) | Compounds and methods for inducing browning of white adipose tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180112 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180112 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181022 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190304 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190402 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6509238 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |